Q: I am puzzled by this company. Other than their SG&A being too high the company seems, on the surface, to be improving. They had a major fire at their plant in PQ which created a supply issue with regards their customer base but that has been resolved. They had some problems with a few other countries trying to ignore their IP but that has pretty much resolved. There are only two countries that can sell their product (krill oil) into China and Canada is one of them. They just announced their first quarter results as below;
Revenues reached $11.3 million, up 270% versus last year
• Gross margin on sales rose to 30.5%
• Nutraceutical segment generated positive Adjusted EBITDA of $1.1 million compared to a loss of $3.2 million a year ago
• Completed first sale in Chinese market and of MaxSimil® in July
• Cash balance of $5 million
• Revised Revenues guidance from $41 to $43 million
I have my opinion on this company but I would appreciate your perspective.
Thanks
Pat Sherman
Revenues reached $11.3 million, up 270% versus last year
• Gross margin on sales rose to 30.5%
• Nutraceutical segment generated positive Adjusted EBITDA of $1.1 million compared to a loss of $3.2 million a year ago
• Completed first sale in Chinese market and of MaxSimil® in July
• Cash balance of $5 million
• Revised Revenues guidance from $41 to $43 million
I have my opinion on this company but I would appreciate your perspective.
Thanks
Pat Sherman